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Abstract
Background: Primary Sjögren’s syndrome (pSS) is a common chronic autoimmune disease characterized by
lymphocytic infiltration of exocrine glands and peripheral lymphocyte perturbation. In the current study, we
aimed to investigate the possible pathogenic implication of autophagy in T lymphocytes in patients with pSS.
Methods: Thirty consecutive pSS patients were recruited together with 20 patients affected by sicca syndrome a
nd/or chronic sialoadenitis and 30 healthy controls. Disease activity and damage were evaluated according to SS
disease activity index, EULAR SS disease activity index, and SS disease damage index. T lymphocytes were analyzed
for the expression of autophagy-specific markers by biochemical, molecular, and histological assays in peripheral
blood and labial gland biopsies. Serum interleukin (IL)-23 and IL-21 levels were quantified by enzyme-linked
immunosorbent assay.
Results: Our study provides evidence for the first time that autophagy is upregulated in CD4+ T lymphocyte salivary
glands from pSS patients. Furthermore, a statistically significant correlation was detected between lymphocyte
autophagy levels, disease activity, and damage indexes. We also found a positive correlation between autophagy
enhancement and the increased salivary gland expression of IL-21 and IL-23, providing a further link between innate
and adaptive immune responses in pSS.
Conclusions: These findings suggest that CD4+ T lymphocyte autophagy could play a key role in pSS pathogenesis.
Additionally, our data highlight the potential exploitation of T cell autophagy as a biomarker of disease activity and
provide new ground to verify the therapeutic implications of autophagy as an innovative drug target in pSS.
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Background
Primary Sjögren’s syndrome (pSS) is a systemic auto-
immune disease characterized by infiltration of exocrine
glands by T and B lymphocytes that, by producing che-
mokines and cytokines, play a fundamental role in
coordinating the chronic inflammatory process [1, 2].
Different subsets of effector T cells, including Th1, Th2,
Th17, regulatory T cells, and follicular helper T cells,
have been demonstrated to participate in the pathogen-
esis of pSS [3–5]. In particular, follicular T-helper cells
seem to be relevant biomarkers of pSS [6] and cytokines
such as interleukin (IL)-21 and IL-23 play a major role
in their modulation [6, 7]. Although the aberrant activa-
tion of the T cell response observed in pSS has partially
been explained by the interaction of T lymphocytes both
with the ductal epithelium and the infiltrating B cells via
costimulatory molecules (i.e., CD40/CD40L) and the
BAFF axis, other immunological mechanisms could play
a crucial role.
Autophagy is a lysosome-mediated catabolic process
that allows cells to degrade damaged organelles and
misfolded proteins, and to recycle nutrients [8]. During
autophagy, portions of cytoplasm are sequestered by
double-membrane vesicles, the autophagosomes, and
degraded after fusion with lysosomes for subsequent
recycling. Autophagy is a genetically regulated process
that requires the activity of autophagy-related gene (Atg)
proteins [9]. Atg5 plays a central role in the autophagic
process by binding to Atg12, acting as a dimeric com-
plex together with Atg16, inducing the curvature of the
phagophore. Atg7 acts like an E1 ubiquitin-activating
enzyme [10]. The Atg5-Atg12 complex contributes to
the conjugation of microtubule-associated protein 1
light-chain 3 (MAP1LC3, also known as LC3, the homo-
log of Atg8 in yeast) to the lipid phosphatidylethanol-
amine. The unlipidated cytosolic form of LC3 is called
LC3-I, whereas the lipidated form, referred to as LC3-II,
is localized into the autophagosomal membranes through-
out the maturation process of the autophagosome, there-
fore being considered an autophagic marker [11]. Other
different genes and proteins finely regulate the autophagy
process, among them: ATG16L1, the main component of
a large protein complex essential for autophagy; the
immunity-associated GTPase family M (IRGM), which
regulates autophagy formation in response to intracellular
pathogens; ATG5, a ubiquitin ligase essential for autopha-
gosomal elongation; HSPA8/HSC70, a protein that binds
to nascent polypeptides to facilitate correct protein fold-
ing; HSP90AA1, involved in the proper folding of specific
target proteins; p62/SQSTM1, a protein that links ubiqui-
tinated proteins to the autophagic machinery to enable
their degradation [12].
Double-membrane autophagosomes have been identi-
fied in both human and murine T lymphocytes [13, 14],
and a crucial role for autophagy in T lymphocyte devel-
opment, survival, and proliferation has been observed
[15, 16]. Moreover, aberrant regulation of autophagy has
been implicated in an increasing number of autoimmune
disorders such as systemic lupus erythematous (SLE),
rheumatoid arthritis, ankylosing spondylitis, multiple
sclerosis, Crohn disease, and vitiligo [17–19]. To date,
only a few studies have been able to evaluate the poten-
tial role of autophagy in pSS induction and development.
In animal models, it has been shown how activation of
the autophagosomal pathway is involved in preventing
or alleviating salivary and lacrimal gland dysfunctions
[20–22]. More recently, Katsiougiannis et al. [23] dem-
onstrated that, in human salivary glands (HSG) cells,
endoplasmic reticulum (ER) stress induced autophagy
and apoptosis in both patients with SS and controls.
However, all the studies focused on the possible role of
the autophagy pathway in salivary gland epithelial cells
and there is no evidence of its effect on T cells.
In this study, we investigated the autophagy process in
human T lymphocytes from salivary gland tissues and
peripheral blood of patients with pSS, hypothesizing a
possible role of autophagy in the increasing survival of
autoreactive T cells. We also assessed the possible rela-
tionship between the level of T lymphocyte autophagy
and the clinical features of pSS. Evidence provided in this
study strongly supports a prominent role for CD4+ T
lymphocyte autophagy in the local immune processes in
salivary glands of patients affected by pSS.
Methods
Patients and samples
Thirty consecutive patients affected by pSS attending the
Sjögren Clinic of Sapienza University of Rome were
enrolled in this study. Patients were classified as pSS
according to the American-European Consensus Group
(AECG) criteria [24]. The presence of other underlying
autoimmune diseases and/or hepatitis C virus infection
was carefully excluded. Patients were characterized for the
presence of extraglandular manifestations such as arthral-
gia/arthritis, cryoglobulinemia, Raynaud’s phenomenon,
and pulmonary, renal, neuro-muscular, or pancreatic
involvement. All pSS patients underwent Schirmer-I, tear
break up time and ocular dye (fluorescein and lissamine
green) tests to assess the presence of keratoconjunctivi-
tis sicca. Disease activity and damage were evaluated
according to Sjögren’s syndrome disease activity index
(SSDAI), EULAR Sjögren’s syndrome disease activity
index (ESSDAI), and Sjögren’s syndrome disease dam-
age index (SSDDI) [25, 26]. Minor salivary glands were
excised through the mucosa of the lower lip. Salivary
gland biopsies taken for histology and gene analysis
were divided in equal parts. One part was embedded in
paraffin for immunohistochemistry (IHC) and the other
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snap frozen in RNAlater solution for real-time polymerase
chain reaction (RT-PCR) analysis. Hematoxylin and eosin
stained tissue sections were evaluated for the presence of
focal and periductal lymphocytic infiltration with the
lymphocyte focus score (FS), determined on the basis of
the number of inflammatory cell aggregates containing
>50 lymphocytes per 4 mm2 [27]. Steroids or hydroxy-
chloroquine were discontinued at least 24 h before
venipuncture. Sera were collected and frozen at −70 °C
until used.
Thirty healthy control (HC) subjects and twenty patients
with sicca syndrome or nonspecific chronic sialoadenitis
(nSS) not satisfying AECG criteria for pSS, sex- and age-
matched, were included as control groups for peripheral
blood and tissue sample analyses, respectively.
Informed consent was obtained from all participants and
the local ethics committee approved the study (Comitato
Etico dell’Università Sapienza di Roma, Prot. 1882/15).
Serology
Antinuclear antibodies were evaluated by indirect
immunofluorescence (IIF); anti-SSA/Ro and anti-SSB/La
antibodies of IgG isotype were measured by commercial
enzyme-linked immunosorbent assay (ELISA; Diamedix,
Miami, FL, USA). Rheumatoid factor (RF) was detected
using an immunonephelometry test (Behring, Marburg,
Germany). Serum IL-23 and IL-21 levels were quantified by
ELISA (Biolegend, San Diego, CA, USA), following the
manufacturer’s instructions.
Cell purification
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by Ficoll-Hypaque (Cedarlane, Euroclone, Pero,
Milan, Italy) density-gradient centrifugation. Separation
of untouched T cells from PBMCs was performed by
immunomagnetic-based depletion of non-T cells using
the Pan T Cell isolation Kit II (MiltenyiBiotec, Bergisch-
Gladbach, Germany). Purity of isolated cells, assessed by
flow cytometer, routinely reached at least 97%.
Flow cytometry
Surface phenotyping of freshly isolated PBMCs was
performed with combinations of monoclonal antibodies
(mAbs) conjugated with fluorescein isothiocyanate
(FITC), phycoerythrin (PE), peridinin chlorophyll protein
(PerCP), or allophycocyanin (APC) as described previ-
ously [18]. Conjugated mAbs against human CD3, CD4,
CD8, CD45RA, CD62L, CD95, HLA-DR, and control
mouse IgG1 (all from BD Biosciences, San Josè, CA,
USA) were used. The naive T cell subset was defined as
CD45RA+CD62L+, whereas the remaining cells com-
prised the memory subsets (CD45RA−CD62L+, central
memory subset; CD45RA+CD62L− and CD45RA−CD62L−,
effector memory subset) [28]. Acquisition was performed
on a FACSCalibur cytometer (BD Biosciences) and 50,000
events per sample were run. Data were analyzed using the
Cell Quest Pro software (BD Biosciences).
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot
To evaluate whether autophagy was detectable in freshly
isolated peripheral T lymphocytes of pSS patients, we
examined the expression of an established set of autop-
hagosomal markers: LC3-II, p62/SQSTM1, and Atg5
[29]. Briefly, purified T lymphocytes were lysed in lysis
buffer (100 mM Tris HCl, pH 8; 150 mM NaCl; 1% Triton
X-100; 1 mM MgCl2; 25 mM Na3VO4) in the presence of
complete protease inhibitor mixture (Sigma-Aldrich,
Milan, Italy). Protein content was determined by the Brad-
ford assay (Bio-Rad Laboratories, Segrate, Milan, Italy).
The samples were loaded onto 15% SDS-PAGE and, after
electrophoresis, proteins were transferred onto
nitrocellulose membrane (Amersham Hybond-ECL; GE
Healthcare Europe, Munich, Germany) by means of a
Trans-Blot transfer cell (Bio-Rad Laboratories). The
membranes were then blocked in TBS containing 0.05
Tween 20 (TBS-T) and 5% skimmed milk for 1 h at room
temperature, rinsed, and incubated with the intended anti-
bodies (Abs) in TBS-T and 5% bovine serum albumin
(BSA). Rabbit anti-human LC3, anti-p62/SQSTM1, and
anti-Atg5 (Cell Signaling Technology, Beverly, MA, USA)
Abs were used as primary antibodies. Excess primary Ab
was removed by washing the membrane in TBS-T. The
membranes were then incubated with peroxidase-
conjugated anti-rabbit IgG Ab (Bio-Rad Laboratories) and
the reaction was developed using SuperSignal West Pico
Chemiluminescent Substrate (Pierce, Thermo Fisher
Scientific, Waltham, MA, USA). To ensure the presence of
equal amounts of protein, the membranes were reprobed
with a rabbit anti-human β-actin Ab (Amersham, Gent,
Belgium). Quantification of protein expression was
performed by densitometry analysis of the autoradiograms
(GS-700 Imaging Densitometer; Bio-Rad Laboratories) [18].
mRNA extraction and quantitative TaqMan RT-PCR gene
expression on salivary gland biopsies
Labial salivary biopsies from patients and controls,
immediately after removal, were stored in RNAlater
solution (Applied Biosystems, Foster City, California,
USA) and processed, as previously described [30]. Sam-
ples were run in triplicate using the Step-One Real-Time
PCR system (Applied Biosystems). Relative quantifica-
tion of gene expression between controls and patients
were determined using the ΔΔCt method, as previously
described [30]. Final values were expressed as relative
quantification.
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Immunohistochemistry (IHC)
Formaldehyde-fixed, paraffin-embedded tissue samples
were obtained from minor labial salivary gland biopsies
of all 30 patients with histologically proven pSS and
from 20 patients with nSS as controls. All samples were
obtained after informed consent during routine diagnostic
procedures. IHC analysis was performed on 3-μm thick
paraffin-embedded sections, as previously described [31].
In most pSS patients and controls, it was possible to
analyze multiple biopsies taken at the same time.
The organizational level of lymphocytic infiltrates in
minor salivary glands was graded by staining of serial
sections using B lymphocytes, T lymphocytes, and
follicular dendritic cell markers. The histological evalu-
ation of the number of foci, the degree of organization
of the mononuclear aggregates, and the presence of
germinal centers (GC) were assessed on the basis of the
histologic appearance and confirmed by CD3, CD20, and
CD21 staining by two blinded observers (FC and GG) [32].
Abs directed against CD20 (Monoclonal Mouse Anti-
Human CD20, 1:100 dilution; Dako, Glostrup, Denmark),
CD21 (Monoclonal Mouse Anti-Human CD21, 1:100 dilu-
tion; Dako), CD3 (Polyclonal Rabbit Anti-Human CD3,
1:100 dilution; Dako), CD4 (Monoclonal Mouse Anti-
Human CD4, 1:100 dilution; Dako), CD8 (Monoclonal
Mouse Anti-Human CD8, 1:100 dilution; Dako), LC3-II
(Rabbit polyclonal anti-Human LC3B, 1:250 dilution;
Abcam, Cambridge, UK), and Atg5 (rabbit monoclonal
anti-human ATG5, 1:100 dilution; Abcam Cambridge,
UK) were used, as previously described [32].
Indirect Immunofluorescence (IIF) and confocal analysis
IIF analysis was performed on paraffin-embedded sec-
tions in order to characterize LC3-II-expressing cells
and to assess whether LC3-II colocalized with Atg5,
CD4, and CD8 cells. Sections were incubated with anti-
human-LC3 (Novus Biologicals, Littleton, CO, USA),
anti-Atg5 (Novus Biologicals), anti-CD3, anti-CD4, and
anti-CD8 Abs (Dako) and then labeled with FITC- or
Rhodamine Red-conjugated anti-mouse or anti-rabbit
Abs plus RNasi (200 ng/mL) and counterstained using
Toto-3 iodide (642/660; Invitrogen, Monza MB, Italy).
Confocal analysis was used to acquire fluorescence
staining.
Statistical analysis
Results were analyzed on SP-SS (version 14.0). The
Mann–Whitney unpaired test was used to compare
quantitative variables in different groups. Spearman’s
rank correlation coefficient was applied for calculation
of the correlation between parallel variables in single
samples. Linear regression analysis was used to dis-
play a best fit line to the data. p values <0.05 were
considered as significant.
Results
Clinical, histologic, and immunophenotypic characteristics
of patients with pSS
The demographic, clinical, and serological characteristics
of the enrolled patients are summarized in Table 1.
All pSS patients had a FS ≥1. Nine pSS patients (30%)
had GCs determined on IHC evaluation of tissue sections.
The peripheral distribution of the main T cell subpop-
ulations was evaluated by flow cytometry (Fig. 1a–c). As
shown in Fig. 1b and c, the percentage of naïve T cells
was significantly reduced, whereas the percentage of ef-
fector memory T cells was significantly higher in pSS pa-
tients, as compared to HC in CD4+ (p = 0.02 for both
naïve and memory T cells) and CD8+ (p = 0.02 and p =
0.04 for naïve and memory T cells, respectively) T cells. A
significantly higher percentage of CD95- and HLA-DR-
positive cells was also detected in CD4+ (p = 0.01 and p =
0.04, respectively) and CD8+ (p = 0.003 and p = 0.005, re-
spectively) T cell subsets (Fig. 1b and c). These findings
suggest a general state of activation within circulating T
cells in the disease population. Nevertheless, the altered
distribution of lymphocyte subsets was independent of
disease activity, organ manifestation, and treatment.
Autophagy levels in freshly isolated T cells from pSS
patients
As shown in Fig. 2a, a great interindividual variability
for LC3-II levels was present in peripheral T lympho-
cytes from pSS patients and no significant differences
in the level of LC3-II were found between patients and
HC. Similarly, there were no significant differences
between lymphocytes from patients and those from HC
in the levels of p62/SQSTM1, and Atg5 (data not
shown). Interestingly, LC3-II levels showed a significant
positive correlation with SSDAI (r = 0.65, p = 0.0001),
ESSDAI (r = 0.47, p = 0.01), and SSDDI (r = 0.42, p = 0.02)
scores (Fig. 2b–d). Since some patients with pSS were
treated with hydroxychloroquine (see Table 1) and this
drug was demonstrated to be a potent inhibitor of autoph-
agy [29], we also evaluated our results in light of bias.
However, no significant difference was found between
hydroxychloroquine-treated and untreated patients.
Autophagy-related genes are upregulated in the salivary
glands of pSS patients and correlate with IL-23p19 and
IL-21 expression levels
We evaluated the expression of atg genes in the salivary
glands of pSS patients by RT-PCR. As shown in Fig. 3,
a significant upregulation of mRNA specific for
ATG16L1 (Fig. 3a), IRGM (Fig. 3b), MAP1LC3A
(Fig. 3c), and the Atg5 protein (Fig. 3d) was observed in
pSS compared to nSS. Interestingly, mRNA specific for
HSPA8/HSC70 (Fig. 3e) and for HSP90AA1 (Fig. 3f )
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Table 1 Demographic, clinical, and serological characteristics of the patients and controls
Primary Sjögren’s syndrome
(n = 30)
Nonspecific chronic sialoadenitis
(n = 20)
Healthy controls
(n = 30)
Age, mean years (range) 59.3 (32–75) 55 (29–77) 50 (25–68)
Sex, female/male 29/1 18/2 25/5
Disease duration, mean years (range) 5.4 (1–26) – –
Xerophtalmia, n (%) 29 (96.6) 12 (60) 0
Xerostomia, n (%) 27 (90) 12 (60) 0
Parotid enlargement, n (%) 11 (36.6) 0 0
Arthralgia/arthritis, n (%) 23 (76.6) 10 (50) 0
Cryoglobulinemia, n (%) 1 (3.3) 0 0
Raynaud’s phenomenon, n (%) 6 (20) 12 (60) 0
Pulmonary involvement, n (%) 1 (3.3) 0 0
Myositis, n (%) 2 (6.6) 0 0
Pancreatic involvement, n (%) 1 (3.3) 0 0
Lymphoma, n (%) 1 (3.3) 0 0
Antinuclear antibodies, n (%) 28 (93.3) 5 (25) 0
Anti-SSA/Ro, n (%) 17 (56.6) 0 0
Anti-SSB/La, n (%) 13 (43.3) 0 0
Rheumatoid factor, n (%) 11 (36.6) 2 (10) 0
IL21, pg/mL median (range) 292 (164–839) 310 (150–999) 301 (177–777)
IL23, pg/mL median (range) 2113 (1838–3567) 2050 (1200–5600) 1913 (1361–10936)
CSS, n (%) 6 (20) – –
Hydroxychloroquine, n (%) 16 (53.3) – –
SSDAI, median (range) 3 (0–8) – –
ESSDAI, median (range) 5.1 (0–24) – –
SSDDI, median (range) 1.7 (1–7) – –
ESSDAI EULAR Sjögren’s syndrome disease activity index, SSDAI Sjögren’s syndrome disease activity index, SSDDI Sjögren’s syndrome disease damage index
Fig. 1 Flow cytometry analysis of distribution of T cell subsets from pSS patients and from HC. For CD4+ and CD8+ T lymphocyte subsets, data
are expressed as the percentage of each subset within the CD4+ or CD8+ population considered as 100%. Data are represented as box plots
(white and grey box plots for HC and pSS patients, respectively) displaying medians, 25th, and 75th percentiles as boxes, and 10th and 90th
percentiles as whiskers. a Peripheral T lymphocytes (%). b CD4+ T cell subset (%) vs HC. c CD8+ T cell subset (%). *p < 0.05 vs HC
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Fig. 2 Western blot analysis of the autophagy marker LC3-II in freshly isolated T cells from pSS patients and from HC, and correlation between
LC3-II levels and clinical index scores. a Blots shown are representative of independent experiments carried out in T cells from healthy controls
(HC; n = 30) and from primary Sjögren’s syndrome (pSS) patients (n = 30). Quantification of LC3-II levels relative to β-actin in normal and pSS T
cells is also shown. Data are represented as box plots (white and grey box plots for HC and pSS patients, respectively) displaying medians, 25th,
and 75th percentiles as boxes, and 10th and 90th percentiles as whiskers. b–d LC3-II levels positively correlate with SSDAI, ESSDAI, and SSDDI
scores. The rho (r) and p values were determined using the Spearman’s rank correlation analysis. Solid lines represent best fits as estimated by
linear regression analysis. ESSDAI EULAR Sjögren’s syndrome disease activity index, SSDAI Sjögren’s syndrome disease activity index, SSDDI
Sjögren’s syndrome disease damage index
Fig. 3 Autophagy and IL-21/IL-23 mRNA gene expression in pSS salivary glands. a–f Relative mRNA quantification of autophagy genes was assessed
by quantitative RT-PCR in minor salivary glands samples obtained from primary Sjögren’s syndrome (pSS) patients and nonspecific chronic sialoadenitis
(nSS). Data are expressed as mean + SEM. g, h Upregulation of IL-23p19 and IL-21 mRNA in salivary glands of pSS patients but not in nSS
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were also significantly upregulated in the salivary
glands of all pSS patients compared to nSS.
Furthermore, a significant upregulation of IL-21 and
IL-23p19 mRNA in salivary glands of pSS patients, but
not in nSS, was observed (Fig. 3g and h). IL-23p19 and IL-
21 mRNA levels were directly and significantly correlated
with the mRNA levels of ATG16L1, ATG5, and IRGM
autophagy genes (Additional file 1: Figure S1). On the
contrary, no differences were observed in serum levels of
IL-23 and IL-21 between patients and controls (Table 1).
Characterization of the tissue expression of autophagy
proteins in salivary glands by IHC, IIF, and confocal
analysis
After demonstrating the strong upregulation of genes
involved in the autophagy pathway, in order to localize
Atg5- and LC3-II-expressing cells, we performed IHC
and IIF. As shown in Fig. 4, a strong and diffuse expres-
sion of LC3-II (Fig. 4b and c) and Atg5 (Fig. 4f and g)
was observed in the salivary glands of pSS patients com-
pared to nSS (Fig. 4a and e). The staining was mostly
localized among infiltrating inflammatory mononuclear
cells and ductal epithelial cells. Moreover, the number of
immunoreactive cells was significantly correlated with
the degree of tissue inflammation as evaluated by FS
(Fig. 4d and h). We also evaluated the expression of
p62/SQSTM1 (Fig. 4j–l). Consistent with the increased
activation of the autophagy pathway, p62/SQSTM1 was
significantly downregulated in the salivary glands of pSS
compared to nSS (p < 0.0001) (Fig. 4l). Interestingly,
patients with GC in salivary glands also had a higher
number of LC3-II- and Atg5-positive cells (data not
shown). We evaluated a possible correlation between the
expression (presence vs absence of the protein) of Atg5
and LC3-II and the clinical data of all our patients, and
no statistically significant difference was observed. No
relevant difference was found in antinuclear antibody,
extractable nuclear antigen, and RF positivity between
the two groups.
To confirm that the immunoreactivity for LC3-II and
Atg5 observed in pSS was truly associated with autopha-
gosomes, we also examined the colocalization of LC3-II
Fig. 4 IHC evaluation of autophagy expression in minor salivary gland biopsies of patients with primary Sjögren’s syndrome (pSS) and nonspecific
chronic sialoadenitis (nSS). a–c Representative photomicrographs showing 3-μm thick paraffin-embedded sections of lip gland biopsy specimens
obtained from nSS (a) and patients with pSS (b, c), stained for LC3-II. d Correlation of LC3-II with FS. LC3-II expression in infiltrating cells by IHC
was correlated with the FS of pSS. e–g. Representative photomicrographs showing 3-μm thick paraffin-embedded sections of lip gland biopsy
specimens obtained from nSS (e) and patients with pSS (f, g), stained for Atg5. h. Atg5 expression in infiltrating cells by IHC was correlated with
the FS of pSS. j–l. p62/SQSTM1 immunoreactivity in lip gland biopsies of nSS (j, k) and pSS patients (l). m Number of p62/SQSTM1 cells in pSS
and nSS. (a–c, e–g, original magnification × 250; j–l original magnification × 400)
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with Atg5. As shown in Fig. 5a and c, a significant colo-
calization of LC3-II and Atg5 was clearly detectable in
the salivary glands of pSS patients, confirming the tissue
autophagy activation.
Finally, in order to characterize the main cellular
source of autophagy in salivary glands of pSS patients,
double immunofluorescent confocal microscopy analysis
was performed using mAbs for CD4, CD8, Atg5, and
CD4
l
CD8
LC3-II
LC3-II
CD4/LC3-II
CD8/LC3-II
o p q
m n
g h i
d e f
a b c
Fig. 5 IIF on pSS salivary glands with inflammatory infiltrates evaluating LC3-II and Atg5 tissue expression in relation to CD4+ T cells. a–c. Representative
image of LC3-II/Atg5 immunostainings of lip gland biopsies of pSS patients: single staining for LC3-II (green) (a) and Atg5 (red) (b), and merged double
staining for LC3-II and Atg5 (c). d–f. Immunolocalization by confocal microscopy of CD4 (green) and Atg5 (red) in pSS salivary gland biopsies.
g–i. Immunolocalization by confocal microscopy of CD8 (green) and Atg5 (red) in pSS salivary gland biopsies. l–n. Immunolocalization by confocal
microscopy of CD4 (green) and LC3-II (red) in pSS salivary gland biopsies. o–q. Immunolocalization by confocal microscopy of CD8 (green) and LC3-II
(red) in pSS salivary gland biopsies. Significant colocalization of Atg5 with CD4 (f) but not CD8 (i), and significant colocalization of LC3-II with CD4 (o)
but not CD8 (q) was detected in the inflamed glands of pSS. (a–q, original magnification × 250)
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LC3-II (Fig. 5). Of note, in the T area, CD3+CD4+ T
cells were the main cellular source of Atg5 and LC3-
II in pSS salivary glands (Fig. 5d–f and l–n,
respectively).
In conclusion, autophagy is increased mainly in CD4+
T lymphocytes from salivary glands, suggesting that the
survival of these cells might initiate autoimmunity and
could play a key role in pSS pathogenesis.
Discussion
In this study, we provided the first demonstration of
autophagy dysregulation in both salivary and peripheral T
lymphocytes from pSS patients. A positive correlation was
found between autophagy level and CD4+ T lymphocyte
infiltration as well as tissue expression of the proinflam-
matory cytokines IL-21 and IL-23 in salivary glands of pSS
patients. Additionally, we found that the level of autoph-
agy in peripheral blood T lymphocytes positively corre-
lated with pSS disease activity indexes.
pSS is a chronic systemic autoimmune disease charac-
terized by the infiltration of T and B lymphocytes into
exocrine glands [1, 2]. Evidence involves both innate and
adaptive immune responses in pSS pathogenesis. The
chronic inflammation provokes ductal epithelial cell
death with exocrine gland dysfunction, contributing to
causing xerostomia and keratoconjunctivitis sicca,
typical of pSS. The upregulation of autophagy-related
markers (at both the mRNA and protein levels) observed
in this study in the salivary glands of pSS, mainly in
CD4+ T cells, is intriguing considering previous studies
showing that T cells, mostly CD4+ T cells, predominate
in the salivary gland lesions and play a crucial role in the
induction and/or maintenance of pSS (e.g., providing a
stimulus for B lymphocytes and promoting the destruc-
tion of the gland through cytotoxicity) [33]. Growing
evidence suggests that autophagy has a positive, cytopro-
tective, and homeostatic role in activated T cells [16]
and dysregulation of this process, as herein observed,
could favor the persistence of pathogenetic CD4+ T cells
in salivary glands. For instance, autophagy supports
metabolic functions of T cells at various stages of their
maturation and effector function and is crucial for T cell
development at the precursor stage, also regulating pep-
tide presentation in stromal cells and professional
antigen-presenting cells. Indeed, in other autoimmune
diseases, and prevalently in SLE, the role of autophagy in
T lymphocytes has been extensively studied: atg5−/− CD8+
T lymphocytes displayed increased cell death, and
atg5−/− CD4+ and CD8+ T cells demonstrated deficient
proliferation after T cell receptor stimulation [15]; atg7-de-
ficient T lymphocytes had increased cell death and also
showed expanded mitochondria, expanded ER content, and
altered calcium flux [33]. Similarly, atg3-deficent mature T
cells showed defective ER homeostasis and mitochondrial
clearance and elevated levels of reactive oxygen species,
which might induce autophagy and consequently the apop-
totic pathway [34]. Although the precise mechanisms lead-
ing to autophagic dysregulation in SLE are still not
understood, this pathway has been implicated in promoting
survival of both human and murine T cells [18, 35].
The role of autophagy in salivary gland homeostasis
and pathology has been studied exclusively in the epithe-
lial cells, demonstrating its prosurvival and homeostatic
role [20, 21]. More recently, Katsiougiannis et al. [23]
investigated the relation between ER stress and autoph-
agy induction in salivary epithelial cells. In this study,
thapsigargin was used as an autophagy inducer, but the
authors speculate that, in real life, other inducers of ER
stress can be responsible for this phenomenon, such as
an epithelial cell viral infection or sympathetic hormone
insults leading to autoimmune initiation, as reflected by
autoantibody redistribution on the cell surface [23].
Therefore, further studies are needed to elucidate the
role and the possible pathogenetic effect of autophagy in
pSS. Our study innovatively investigates the possible
pathogenetic role of autophagy in a different cell popula-
tion, T cells, demonstrating that autophagy is increased
in salivary glands T lymphocytes and speculating that
this could promote the survival of a subset of cells that
can initiate autoimmunity. In our study, the autophagy
level in salivary glands was also significantly correlated
with FS and damage indexes. These results are expected
because patients with a higher FS or GCs in their
salivary glands are more likely to have worse disease and
prognosis [36, 37]. Moreover, according to the prognostic
role of T cell autophagy in pSS, it would be interesting to
evaluate the role of autophagy in lymphoproliferative
complications in pSS. In fact, the identification of bio-
markers that could be clinically valuable for making diag-
noses and determining disease progression in lymphoid
malignancies are currently lacking.
Previous studies have demonstrated a role for autoph-
agy in modulating the expression of IL-23, a cytokine
strongly implicated in the pathogenesis of pSS and
correlated with clinical manifestations [31]. Interestingly,
we found a significant correlation between the level of
Atg genes and that of IL-23p19 and IL-21 in salivary
glands from pSS patients. Modulation of IL-23 production
by autophagy has been recently demonstrated, suggesting
a role of autophagy in bridging innate and adaptive
immune responses [38]. The correlation between autoph-
agy gene expression and IL-21 in the inflamed salivary
glands of pSS represents, in our opinion, an important
and novel finding. Although no direct correlation between
autophagy and IL-21 production has been demonstrated,
the differentiation of IL-21-producing Th17 cells seems to
be dependent on MHC II expression by CD11c+ cells [39].
In this regard, it has been recently demonstrated that
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pathogens and pattern-recognition receptors can directly
activate autophagy to upregulate MHC II presentation
[40]. In light of this evidence, the autophagy activation
in pSS salivary glands might be the result of a viral or
bacterial stimulation and might be involved in driving
the differentiation of IL-21-producing cells. Nevertheless,
in our study no difference in serum levels of IL-23 and
IL-21 between patients with pSS and HC was observed.
We speculate that the discrepant results in blood com-
pared to tissue might reflect local rather than systemic
cytokine modulation.
Finally, as expected, circulating T cells in the pSS popu-
lation were demonstrated to have a general state of activa-
tion, given the imbalance of naïve and memory T cell
distribution and the increased expression of T cell activa-
tion markers. Interestingly, despite the absence of signifi-
cant differences in terms of autophagy levels between pSS
and controls, a significant correlation between peripheral
T lymphocyte autophagy and disease activity and damage
indexes in pSS was found.
Conclusions
This is the first study that investigates autophagy in T
lymphocytes in patients with pSS. According to our
results, an increase in the autophagy levels in T lympho-
cytes from salivary glands in pSS patients could represent
the local origin of the pathogenic process in which an
immune stimulus could activate the autophagic pathway
and therefore promote the survival of a subset of lympho-
cytes. Our findings may be disease-specific or simply
reflect the general increase in inflammation seen in this
condition and further studies over larger cohorts of
patients are mandatory to validate the possible use of T
lymphocyte autophagy-related molecules as prognostic
peripheral biomarkers and to evaluate the implications of
autophagy as a therapeutic target in pSS.
Additional file
Additional file 1: Figure S1. IL-23p19 and IL-21 mRNA level correlations
with mRNA levels of autophagy genes. IL-23p19 and IL-21 mRNA levels
were directly and significantly correlated with the mRNA levels of ATG16L1,
ATG5, and IRGM autophagy genes. (TIF 50 kb)
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